Tryptamine Therapeutics raises A$6M to advance psychedelic pipeline
The placement is a bright spot in an otherwise quiet period for psychedelics industry financing.
The post Tryptamine Therapeutics raises A$6M to advance psychedelic pipeline appeared first on Green Market Report.
